Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Josef, Friedl"'
Autor:
Werner, Scheithauer, Gabriela, Kornek, Gerald, Prager, Nadja, Stranzl, Friedrich, Laengle, Martin, Schindl, Josef, Friedl, Julia, Klech, Sabine, Roethlin, Christoph, Zielinski
Publikováno v:
Journal of gastrointestinal oncology. 7(2)
Combination chemotherapy regimens including fluoropyrimidines as well as albumin-bound paclitaxel have shown promising results in patients with metastatic pancreatic adenocarcinoma (mPC). Based on the recently described excellent therapeutic index of
Autor:
Josef Thaler, Ansgar Weltermann, Werner Linkesch, Siegfried Sormann, Dietmar Geissler, Elisabeth Pittermann, Michael Fillitz, Michael Steurer, Markus Müller, Paul A. Kyrle, Richard Greil, Josef Friedl, Klaus Geissler, Peter Krippl, Ingrid Pabinger, Simon Panzer, Heinz Ludwig, Günther Gastl, Sibylle A. Kozek-Langenecker, Paul Knöbl, Alois Lang
Publikováno v:
Wiener klinische Wochenschrift. 124:111-123
Immune Thrombocytopenia (ITP) is a rare and - in most patients - mild disease, but might be associated with severe or even life-threatening bleeding complications. The treatment of ITP has partly changed in recent years, due to new therapeutic option
Autor:
Josef Friedl, Monika Sachet, Georg Stary, Anton Stift, M. Ploder, Michaela Hassler, Michael Bergmann
Publikováno v:
European Journal of Clinical Investigation. 39:1000-1009
Background Induction of cytotoxic T cells by dendritic cells (DCs) is a promising approach to tumour-immunotherapy. A standardized effective preparation of DCs remains a challenge for clinical application. Material and methods We assessed whether inf
Autor:
Peter Dubsky, Markus Dettke, Anton Stift, Thomas Bachleitner-Hofmann, Josef Friedl, Michael Gnant, Monika Sachet, Hubert Hayden, Michaela Hassler
Publikováno v:
Journal of Immunotherapy. 32:638-654
Cryopreservation of immature or mature dendritic cells (DC) has been proposed as a suitable method to gain large numbers of DC for immunotherapeutic trials against cancer. However, clinical studies using cryopreserved DC have demonstrated only limite
Autor:
Alfred Beham, Hermann Katinger, Bruno Niederle, Regina Voglauer, Josef Friedl, Guido Stadler, Berthold Streubel, Roswitha Pfragner, Johannes Grillari, Anton Stift, Michael Gnant, Matthias Wieser
Publikováno v:
European Journal of Cancer. 44:866-875
Maintenance of telomere length has been reported to be an absolute requirement for unlimited growth of human tumour cells and in about 85% of cases, this is achieved by reactivation of telomerase, the enzyme that elongates telomeres. Only in rare cas
Publikováno v:
European Surgery. 39:158-166
BACKGROUND: The advances in surgical techniques and the development of new therapeutic agents have improved the prognosis of esophageal cancer in the past decades. However, the 5 year overall survival still remains poor. The bleak prognosis has led t
Autor:
Anton Stift, Josef Friedl, Michaela Strohschneider, Thomas Bachleitner-Hofmann, Michael Gnant, Roswitha Pfragner, Hubert Hayden, Peter Krieger, Monika Sachet, Peter Dubsky, Sebastian F. Schoppmann
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:4571-4577
Background: In vitro and in vivo studies have shown that dendritic cells (DCs) can stimulate antitumor T cell responses against medullary thyroid carcinoma (MTC). However, despite promising results in selected cases, the clinical efficacy of DC immun
Publikováno v:
Clays and Clay Minerals. 52:221-226
Ferrihydrite is a poorly crystalline Fe oxide of which 2-(XRD)line and 6-line varieties are commonly used in experiments, although species with intermediate numbers of peaks have been found in nature. To simulate nature, we synthesized two continuous
Autor:
Christine Brostjan, Anton Stift, Anna Zommer, Sebastian Roka, Anita Bayer, Alexander Gornikiewicz, Raimund Jakesz, Rubina Yaghubian, Thomas Benkö, Michael Gnant, Josef Friedl, Günther Steger
Publikováno v:
Cancer. 98:2291-2301
BACKGROUND A promising treatment approach for patients with malignant disease that recently has found its way into clinical trials is based on vaccination with autologous dendritic cells loaded with tumor antigens. However, adequate assays for monito
Autor:
G. Schueller, Christine Brostjan, T. Benkoe, T. Zontsich, Josef Friedl, Anton Stift, Michael Gnant, K. Radelbauer, P. Dubsky, Thomas Bachleitner-Hofmann, Raimund Jakesz
Publikováno v:
Scopus-Elsevier
Purpose: Dendritic cell (DC)-based immunotherapy is rapidly emerging as a viable tool in cancer treatment. This approach has been used mostly in patients in the presence of defined tumor antigens such as melanoma. In this study, cancer patients with